The intestinal mucosa undergoes a continual process of proliferation, differentiation and apoptosis, which is regulated by multiple signaling pathways. Notch signaling is critical for the control of intestinal stem cell maintenance and differentiation. However, the precise mechanisms involved in the regulation of differentiation are not fully understood. Previously, we have shown that tuberous sclerosis 2 (TSC2) positively regulates the expression of the goblet cell differentiation marker, MUC2, in intestinal cells. Using transgenic mice constitutively expressing a dominant negative TSC2 allele, we observed that TSC2 inactivation increased mTORC1 and Notch activities, and altered differentiation throughout the intestinal epithelium, with a marked decrease in the goblet and Paneth cell lineages. Conversely, treatment of mice with either Notch inhibitor dibenzazepine (DBZ) or mTORC1 inhibitor rapamycin significantly attenuated the reduction of goblet and Paneth cells. Accordingly, knockdown of TSC2 activated, whereas knockdown of mTOR or treatment with rapamycin decreased, the activity of Notch signaling in the intestinal cell line LS174T. Importantly, our findings demonstrate that TSC2/mTORC1 signaling contributes to the maintenance of intestinal epithelium homeostasis by regulating Notch activity. Cell Death and Disease (2015) 6, e1631; doi:10.1038/cddis.2014.588; published online 5 February 2015The intestinal epithelium undergoes a process of constant and rapid renewal. The intestinal crypts of Lieberkühn, a highly dynamic niche with multipotent stem cells residing in its lower third, generate new cells that eventually differentiate into the four specialized cell types of the small intestine, namely absorptive enterocytes and secretory lineages known as enteroendocrine, goblet and Paneth cells.1,2 Differentiated enterocytes, which make up the majority of the cells of the gut mucosa, then undergo a process of apoptosis and are extruded into the lumen.1,3 The mechanisms that regulate stem cell maintenance, proliferation, differentiation and apoptosis must be precisely orchestrated to ensure proper organ maintenance. 3 An imbalance in this highly-regimented and orderly process within the intestinal crypts is associated with a number of intestinal pathologies, including colorectal cancer, inflammatory bowel disease (IBD) and necrotizing enterocolitis. [4][5][6] To date, the cellular mechanisms regulating intestinal cell differentiation are not entirely known.Tuberous sclerosis is an autosomal dominant disorder caused by the mutations in the tuberous sclerosis 2 (TSC2) gene.7 TSC1 and TSC2 function as a complex and exert their tumor suppressor function by negatively regulating the mTOR pathway.8 mTOR is a member of the phosphatidylinositol 3-kinase-related kinase family and regulates protein translation, cell cycle progression and cell proliferation. 9 The TOR signaling events are essential for epithelial growth, morphogenesis and differentiation in the vertebrate intestine.10 mTOR exists in two complexes: mTORC1 (c...